Loading viewer...
investor_presentation
Format: PDF investor_presentation
1 Building a Full -spectrum Genome Editing Company 2018
Building a Full -spectrum Genome Editing Company
Intellia Therapeutics Legal Disclaimers
This presentation contains “forward -looking statements” ofIntellia
Therapeutics, Inc.within themeaning ofthePrivate Securities Litigation
Reform Actof1995 .These forward -looking statements include, butare
notlimited to,express orimplied statements regarding Intellia’s ability to
advance and expand theCRISPR/Cas 9technology todevelop into
human therapeutic products, aswell asourCRISPR/Cas 9intellectual
property portfolio ;ourability toachieve stable oreffective genome
editing ;ourability toadminister multiple doses ofourCRISPR/Cas 9
product candidates ;the potential timing and advancement ofour
preclinical studies, including continuing non-human primate studies for
ourATTR program andother programs, andclinical trials;thetiming and
potential achievement ofmilestones toadvance ourpipeline ;ourability to
replicate results achieved inourpreclinical studies inanyfuture studies,
including human clinical trials;thepotential development ofexvivo cell
therapeutics ofalltypes, and those targeting WT1inparticular, using
CRISPR/Cas 9technology ;ourability tocontinue toconduct successful
IND-enabling studies ofalead ATTR development candidate and
subsequently submitting anINDapplication bytheendof2019 thatwill
beaccepted bytheregulatory agencies ;ourintent topresent additional
data fororgans beyond theliver, additional insertion/repair data, and
preclinical data insupport ofourfirst exvivo programs onimmuno -
oncology and autoimmune/inflammation indications during 2018 ;the
expansion ofourfully automated bioinformatics platform ;ourability to
advance adevelopment candidate forasecond indication bylate2018 ;
ourpotential ability toconduct apre-INDmeeting withtheFDA forATTR ;
theintellectual property position and strategy ofIntellia’s licensors or
other parties from which itderives rights ;actions bygovernment
agencies ;theimpact ofourcollaborations onourdevelopment programs ;
Preview truncated — download the full document for the complete content.
investor_presentation
84 Pages
investor_presentation
17 Pages
TransAlta
investor_presentation
NetEase
investor_presentation
Broadstone Net Lease